Gonzalo De Miquel
Chief Medical Officer & Executive Vice President
pharmacovigilance and regulatory
vectura.
Switzerland
Biography
Mr. Gonzalo De Miquel is Chief Medical Officer & Executive Vice President - Development of the company. Gonzalo De Miquel joined Vectura in February 2017. Gonzalo has highly relevant medical and product development experience ranging from pharmacovigilance and regulatory through to early and late stage clinical development and medical affairs. Prior to joining Vectura, Gonzalo was Vice President of Clinical Development at Astra Zeneca with responsibility for the overall strategy, organisation, resource assignment and project prioritisation across Astra Zeneca’s portfolio. Gonzalo trained in Internal medicine and Rheumatology practising for six years in Barcelona before moving into the pharmaceutical industry. Gonzalo has held senior positions including global clinical lead for respiratory autoimmunity at Boehringer working in early clinical development as well as the late-stage and launch of Spiriva in Spain and with Almirall as Director of Global Clinical Development, successfully leading their aclidinium franchise development through to FDA and EMA approvals in 2012 and previously as their head of Global Medical Affairs.
Research Interest
Internal medicine and Rheumatology
